The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized, multi-center study of carfilzomib, lenalidomide, and dexamethasone (KRd) with or without daratumumab (D) in patients with newly diagnosed multiple myeloma (NDMM): The ADVANCE clinical trial.
 
Carl Landgren
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Medscape
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen
Research Funding - Amgen (Inst); Janssen (Inst); Menarini Silicon Biosystems (Inst); Pfizer (Inst); Sebia (Inst)
 
Jing Ye
No Relationships to Disclose
 
Jens Hillengass
Employment - Roswell Park Cancer Institute
Honoraria - BeiGene; Cancer Network; IntegrityCE; Janssen Biotech; Targeted Oncology
Consulting or Advisory Role - Angitia; Janssen Biotech; Prothena; Regeneron; Regeneron; Sebia
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst)
 
Douglas Sborov
Consulting or Advisory Role - Abbvie; Arcellx; AstraZeneca; BiolineRx; Bristol-Myers Squibb/Celgene; Genentech; GlaxoSmithKline; Janssen; Opna Bio; Pfizer; Sanofi
Research Funding - Pfizer
 
James Hoffman
No Relationships to Disclose
 
Benjamin Diamond
No Relationships to Disclose
 
David Coffey
Speakers' Bureau - MJH Healthcare Holdings, LLC
 
Marcella Kaddoura
No Relationships to Disclose
 
Abhishek Pandey
No Relationships to Disclose
 
Kellye Koubek
No Relationships to Disclose
 
Stephanie Mompoint
No Relationships to Disclose
 
Sindy Gutierrez
No Relationships to Disclose
 
Caterine Diaz
No Relationships to Disclose
 
Michelle Armogan
No Relationships to Disclose
 
Rachid Baz
Consulting or Advisory Role - Cellectar; Janssen; Pfizer
Research Funding - abbfvie; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Regenaron
 
Robert Orlowski
Stock and Other Ownership Interests - Asylia Therapeutics, Inc.
Consulting or Advisory Role - BioTheryX; Bristol-Myers Squibb; GlaxoSmithKline; IASO Biotherapeutics; Janssen; Lytica Therapeutics; Meridian Therapeutics; Monte Rosa Therapeutics; Regeneron; Sanofi; Takeda
Research Funding - Asylia Therapeutics, Inc. (Inst); CARsgen Therapeutics (Inst); Celgene/Bristol-Myers Squibb (Inst); Exelixis (Inst); Heidelberg Pharma (Inst); Janssen Biotech (Inst); Sanofi/Aventis (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Asylia Therapeutics, Inc.
 
Thomas Jandl
No Relationships to Disclose
 
Neha Korde
Honoraria - Cancer Network; Clinical Care Options; Intellisphere; Onc Live; PER; Remedy Health
Consulting or Advisory Role - Janssen Oncology
Research Funding - Abbvie; Amgen; Epizyme; Janssen
Travel, Accommodations, Expenses - Dava oncology
 
Kenneth Shain
No Relationships to Disclose
 
Dickran Kazandjian
Honoraria - Alpha Sight; Curio Science; FLASCO; Gerson Lehrman Group; MJH Life Sciences
Consulting or Advisory Role - Arcellx; Dedham Group; Focus Group Health; Sanofi
Speakers' Bureau - Karyopharm Therapeutics
Research Funding - Karyopharm Therapeutics; Regeneron